Triple
T14008624
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CoronaVac |
E337018
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | inactivated virus vaccine |
C33400
|
CONCEPT FINISHED |
Disambiguation candidates (1 decision)
The exact options the model was shown at each disambiguation step, with the option it chose highlighted — the evidence behind this triple's disambiguated ids.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: inactivated virus vaccine Context triple: [CoronaVac, instanceOf, inactivated virus vaccine]
-
A.
live attenuated vaccine
A live attenuated vaccine is a vaccine made from a weakened form of a pathogen that can still replicate but does not cause disease in healthy individuals, stimulating a strong and lasting immune response.
-
B.
adenovirus vector vaccine
An adenovirus vector vaccine is a type of vaccine that uses a harmless, modified adenovirus to deliver genetic instructions for producing a pathogen’s antigen, thereby stimulating an immune response without causing the disease.
-
C.
single-dose vaccine
A single-dose vaccine is an immunization product designed to confer effective and lasting protection against a specific disease with only one administered dose, eliminating the need for follow-up booster shots.
-
D.
Ebola vaccine
An Ebola vaccine is a biomedical product designed to stimulate the immune system to provide protection against infection by the Ebola virus.
-
E.
neuraminidase inhibitor
A neuraminidase inhibitor is an antiviral drug that blocks the activity of the viral neuraminidase enzyme, preventing the release and spread of influenza viruses from infected cells.
- F. None of above. chosen
Provenance (1 batch)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d81c645c5c8190b1fd16a285a1b78a |
elicitation | completed |
Created at: April 9, 2026, 10:19 p.m.